Cargando…

Barriers to global pharmacometrics: educational challenges and opportunities across the globe

Detalles Bibliográficos
Autores principales:	Michelet, Robin, Aulin, Linda B. S., Borghardt, Jens M., Costa, Teresa Dalla, Denti, Paolo, Ibarra, Manuel, Ma, Guangda, Meibohm, Bernd, Pillai, Goonaseelan (Colin), Schmidt, Stephan, Hennig, Stefanie, Kloft, Charlotte
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272295/ https://www.ncbi.nlm.nih.gov/pubmed/36960632 http://dx.doi.org/10.1002/psp4.12940

Ejemplares similares

Pharmacometrics: Opportunity for Reducing Disease Burden in the Developing World: The Case of Africa
por: Pillai, G, et al.
Publicado: (2013)

Role of pharmacometrics and systems pharmacology in facilitating efficient dose optimization in oncology
por: Jayachandran, Priya, et al.
Publicado: (2023)

Applied Pharmacometrics (AAPS Advances in the Pharmaceutical Sciences Series)
por: Meibohm, Bernd
Publicado: (2015)

Editorial: Pharmacometrics—tools to assure optimal medicine use in low- and middle-income countries
por: Abulfathi, Ahmed A., et al.
Publicado: (2022)

Pharmacometrics: Focus on the Patient
por: Dumitrescu, T Pene, et al.
Publicado: (2015)

What “Impact” Do NLME Publications Have Outside Our Community?
por: Hennig, Stefanie, et al.
Publicado: (2020)

Pharmacometrics in Australasia—Twenty Years of Population Approach Group of Australia and New Zealand
por: Hennig, Stefanie, et al.
Publicado: (2019)

Opinion: The Pharmacometrics of Infectious Disease
por: Davies, G R, et al.
Publicado: (2013)

Time to Expect More From Pharmacometrics
por: Barrett, Jeffrey S.
Publicado: (2020)

Perspective on the State of Pharmacometrics and Systems Pharmacology Integration
por: Trame, Mirjam N., et al.
Publicado: (2018)

Iberoamerican Pharmacometrics Network Congress 2018 Report: Fostering Modeling and Simulation Approaches for Drug Development and Regulatory and Clinical Applications in Latin America
por: Ibarra, Manuel, et al.
Publicado: (2019)

Artificial Intelligence and Pharmacometrics: Time to Embrace, Capitalize, and Advance?
por: Chaturvedula, Ayyappa, et al.
Publicado: (2019)

Meeting Report: PMDA Public Workshop on Pharmacometrics at Japan
por: Kijima, Shinichi, et al.
Publicado: (2020)

Response to “Pharmacometric Approach to Evaluate Drug Dosing Adherence”
por: Ding, Junjie, et al.
Publicado: (2020)

R and nlmixr as a gateway between statistics and pharmacometrics
por: Fidler, Matthew, et al.
Publicado: (2021)

Inhaled Therapy in Respiratory Disease: The Complex Interplay of Pulmonary Kinetic Processes
por: Borghardt, Jens Markus, et al.
Publicado: (2018)

Where Do PBPK Models Stand in Pharmacometrics and Systems Pharmacology?
por: Jamei, Masoud
Publicado: (2020)

Variable or variate? A conundrum in pharmacometrics exposure–response models
por: Grisic, Ana‐Marija, et al.
Publicado: (2022)

Pharmacometrics Markup Language (PharmML): Opening New Perspectives for Model Exchange in Drug Development
por: Swat, MJ, et al.
Publicado: (2015)

The Mathematical and Computational Sciences Special Interest Group of the International Society of Pharmacometrics
por: Moore, Helen
Publicado: (2019)

The Asian Pharmacometrics Network: The historical background, establishment, objectives and roles, and recent activities
por: Kaibara, Atsunori, et al.
Publicado: (2022)

Approaching Pharmacometrics as a Paleontologist Would: Recovering the Links Between Drugs and the Body Through Reconstruction
por: Craig, M, et al.
Publicado: (2016)

Pharmacometrics, Physiologically Based Pharmacokinetics, Quantitative Systems Pharmacology—What's Next?—Joining Mechanistic and Epidemiological Approaches
por: Schmidt, Stephan, et al.
Publicado: (2019)

Dr. Hartmut Derendorf, PhD, a world‐renowned expert in pharmacokinetics and pharmacometrics (1953–2020)
por: Sinha, Vikram, et al.
Publicado: (2021)

Circulating tumor DNA: Opportunities and challenges for pharmacometric approaches
por: Ribba, Benjamin, et al.
Publicado: (2023)

A multistate tuberculosis pharmacometric model: a framework for studying anti-tubercular drug effects in vitro
por: Clewe, Oskar, et al.
Publicado: (2016)

CPT: Pharmacometrics & Systems Pharmacology – Inception, Maturation, and Future Vision
por: Rowland Yeo, Karen, et al.
Publicado: (2021)

Metaheuristics for pharmacometrics
por: Kim, Seongho, et al.
Publicado: (2021)

Translational Pharmacometric Evaluation of Typical Antibiotic Broad‐Spectrum Combination Therapies Against Staphylococcus Aureus Exploiting In Vitro Information
por: Wicha, SG, et al.
Publicado: (2017)

Approach to Management of Eyes with no Light Perception after Open Globe Injury
por: Bhagat, Neelakshi, et al.
Publicado: (2016)

Current Use and Developments Needed for Optimal Design in Pharmacometrics: A Study Performed Among DDMoRe's European Federation of Pharmaceutical Industries and Associations Members
por: Mentré, F, et al.
Publicado: (2013)

Optimized Alectinib Dose Regimen for Treatment of Patients With ALK‐Positive Non‐Small Cell Lung Cancer Based on Robust Pharmacometric Analyses and Clinical Evidence
por: Frey, Nicolas, et al.
Publicado: (2021)

Promoting Science Literacy and Awareness across the Globe: the Role of Scientists as Science Ambassadors
por: Tuttle, Matthew J., et al.
Publicado: (2023)

Ulcerative Colitis and Acute Severe Ulcerative Colitis Patients Are Overlooked in Infliximab Population Pharmacokinetic Models: Results from a Comprehensive Review
por: Démaris, Alix, et al.
Publicado: (2022)

Development of a Model-Informed Dosing Tool to Optimise Initial Antibiotic Dosing—A Translational Example for Intensive Care Units
por: Weinelt, Ferdinand Anton, et al.
Publicado: (2021)

Commentary on Pharmacometrics for Immunotherapy
por: Garrido, MJ, et al.
Publicado: (2017)

Pharmacometrics and/or Systems Pharmacology
por: van der Graaf, Piet H.
Publicado: (2019)

The status of pharmacometrics in pregnancy: highlights from the 3(rd) American conference on pharmacometrics
por: van Hasselt, J G Coen, et al.
Publicado: (2012)

Efficient and relevant stepwise covariate model building for pharmacometrics
por: Svensson, Robin J., et al.
Publicado: (2022)

Microdialysis of Voriconazole and its N-Oxide Metabolite: Amalgamating Knowledge of Distribution and Metabolism Processes in Humans
por: Schulz, Josefine, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4hh1g0j8ol20itedn4hpspqr9c